Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine in patients with sickle cell disease
2012-004892-37Phase 3Terminated
- Sponsor
- Academic Medical Center
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetylcysteine in sickle cell disease (SCD), sponsored by Academic Medical Center. Primary endpoint: Frequency of sickle cell disease-related pain in daily life. Started Mar 2013; status: terminated.
02
Drugs
acetylcysteine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on 2012-004892-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004892-37.